Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients

[1]  B. McCrindle,et al.  Increased left ventricular myocardial extracellular volume is associated with longer cardiopulmonary bypass times, biventricular enlargement and reduced exercise tolerance in children after repair of Tetralogy of Fallot , 2016, Journal of Cardiovascular Magnetic Resonance.

[2]  T. Geva,et al.  Myocardial ECV Fraction Assessed by CMR Is Associated With Type of Hemodynamic Load and Arrhythmia in Repaired Tetralogy of Fallot. , 2016, JACC. Cardiovascular imaging.

[3]  V. Murthy,et al.  Myocardial tissue remodeling after orthotopic heart transplantation: a pilot cardiac magnetic resonance study , 2016, The International Journal of Cardiovascular Imaging.

[4]  M. Gutberlet,et al.  Myocardial deformation parameters predict outcome in patients with repaired tetralogy of Fallot , 2015, Heart.

[5]  A. Greiser,et al.  Diffuse Myocardial Fibrosis in Children After Heart Transplantations: A Magnetic Resonance T1 Mapping Study , 2015, Transplantation.

[6]  P. Kellman,et al.  Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage , 2015, Journal of the American Heart Association.

[7]  Sanjiv J. Shah,et al.  Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone , 2015, Circulation. Heart failure.

[8]  L. Lund,et al.  The Registry of the International Society for Heart and Lung Transplantation: Eighteenth Official Pediatric Heart Transplantation Report--2015; Focus Theme: Early Graft Failure. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  B. Gerber,et al.  Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T , 2015, Journal of Cardiovascular Magnetic Resonance.

[10]  Jonathan D. Suever,et al.  Children with obesity have cardiac remodeling and dysfunction: a cine DENSE magnetic resonance imaging study , 2015, Journal of Cardiovascular Magnetic Resonance.

[11]  Yong-Jin Kim,et al.  Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis. , 2015, Radiology.

[12]  G. Korosoglou,et al.  T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. , 2015, European heart journal cardiovascular Imaging.

[13]  Wei Zhang,et al.  Clinical validation of free breathing respiratory triggered retrospectively cardiac gated cine balanced steady-state free precession cardiovascular magnetic resonance in sedated children , 2015, Journal of Cardiovascular Magnetic Resonance.

[14]  David M Higgins,et al.  Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study , 2014, Journal of Cardiovascular Magnetic Resonance.

[15]  S. Colan,et al.  Myocardial extracellular remodeling is associated with ventricular diastolic dysfunction in children and young adults with congenital aortic stenosis. , 2014, Journal of the American College of Cardiology.

[16]  D. Stub,et al.  Diffuse myocardial fibrosis evaluated by post-contrast t1 mapping correlates with left ventricular stiffness. , 2014, Journal of the American College of Cardiology.

[17]  Simon G. Williams,et al.  Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy , 2014, Journal of Cardiovascular Magnetic Resonance.

[18]  A. Greiser,et al.  Diffuse myocardial fibrosis following tetralogy of Fallot repair: a T1 mapping cardiac magnetic resonance study , 2014, Pediatric Radiology.

[19]  M. Fishbein,et al.  Correlation between myocardial fibrosis and restrictive cardiac physiology in patients undergoing retransplantation , 2013, Clinical transplantation.

[20]  M. Robson,et al.  Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement , 2013, Journal of Cardiovascular Magnetic Resonance.

[21]  Tobias Schaeffter,et al.  Standardization of T1 measurements with MOLLI in differentiation between health and disease – the ConSept study , 2013, Journal of Cardiovascular Magnetic Resonance.

[22]  Richard B. Thompson,et al.  Late gadolinium enhancement in cardiac transplant patients is associated with adverse ventricular functional parameters and clinical outcomes. , 2013, The Canadian journal of cardiology.

[23]  Andrew S Flett,et al.  Comprehensive Validation of Cardiovascular Magnetic Resonance Techniques for the Assessment of Myocardial Extracellular Volume , 2013, Circulation. Cardiovascular imaging.

[24]  Margaret A. Tresler,et al.  Ten yr of pediatric heart transplantation: A report from the Pediatric Heart Transplant Study , 2013, Pediatric transplantation.

[25]  Andrew S Flett,et al.  Human non-contrast T1 values and correlation with histology in diffuse fibrosis , 2013, Heart.

[26]  James O. Mudd,et al.  T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. , 2012, Radiology.

[27]  Jaetaek Kim,et al.  Mechanisms and Consequences of Inflammatory Signaling in the Myocardium , 2012, Current Hypertension Reports.

[28]  P. Kellman,et al.  Association Between Extracellular Matrix Expansion Quantified by Cardiovascular Magnetic Resonance and Short-Term Mortality , 2012, Circulation.

[29]  M. Robson,et al.  Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.

[30]  David A Bluemke,et al.  T1 mapping of the myocardium: Intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region , 2012, Journal of Cardiovascular Magnetic Resonance.

[31]  P. Rainer,et al.  Cardiac fibrosis in human transplanted hearts is mainly driven by cells of intracardiac origin. , 2012, Journal of the American College of Cardiology.

[32]  S. Miyamoto,et al.  Longitudinal Myocardial Deformation is Selectively Decreased After Pediatric Cardiac Transplantation: A Comparison of Children 1 Year After Transplantation With Normal Subjects Using Velocity Vector Imaging , 2012, Pediatric Cardiology.

[33]  D. Pennell,et al.  The relationship between interstitial fibrosis and contractile function in HCM: a combined T1-mapping and CSPAMM tagging study , 2012, Journal of Cardiovascular Magnetic Resonance.

[34]  Jerry L Prince,et al.  Assessment of distribution and evolution of Mechanical dyssynchrony in a porcine model of myocardial infarction by cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.

[35]  E. Wellnhofer,et al.  Everolimus Prevents Endomyocardial Remodeling After Heart Transplantation , 2011, Transplantation.

[36]  Gerrit A. Meijer,et al.  Rapid Quantification of Myocardial Fibrosis: A New Macro-Based Automated Analysis , 2010, Cellular Oncology.

[37]  P. Sengupta,et al.  Natural history of left ventricular mechanics in transplanted hearts: relationships with clinical variables and genetic expression profiles of allograft rejection. , 2010, JACC. Cardiovascular imaging.

[38]  M. Schieber,et al.  Comparative Evaluation of Left and Right Ventricular Endomyocardial Biopsy: Differences in Complication Rate and Diagnostic Performance , 2010, Circulation.

[39]  M. Hayward,et al.  Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans , 2010, Circulation.

[40]  S. Yoo,et al.  Early changes in right ventricular function and their clinical consequences in childhood and adolescent dilated cardiomyopathy , 2010, Cardiology in the Young.

[41]  F. Pezzella,et al.  Hypoxia and myocardial remodeling in human cardiac allografts: a time-course study. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[42]  M. Fishbein,et al.  Clinico‐pathologic findings in end‐stage pediatric heart transplant grafts , 2009, Pediatric transplantation.

[43]  Stefan Neubauer,et al.  Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations , 2009, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[44]  E. Wellnhofer,et al.  Prognostic impact of microvasculopathy on survival after heart transplantation: evidence from 9713 endomyocardial biopsies. , 2009, Circulation.

[45]  K. Fujiwara,et al.  ECM remodeling in hypertensive heart disease. , 2007, The Journal of clinical investigation.

[46]  Douglas L Mann,et al.  Mechanisms and models in heart failure: the biomechanical model and beyond. , 2005, Circulation.

[47]  David M Higgins,et al.  Modified Look‐Locker inversion recovery (MOLLI) for high‐resolution T1 mapping of the heart , 2004, Magnetic resonance in medicine.

[48]  E. Tuzcu,et al.  Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome. , 2002, Journal of the American College of Cardiology.

[49]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association , 2002, The international journal of cardiovascular imaging.

[50]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[51]  C. Lorenz,et al.  Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. , 2001, Radiology.

[52]  P. Binkley,et al.  Quantitative investigation of cardiomyocyte hypertrophy and myocardial fibrosis over 6 years after cardiac transplantation. , 1998, Journal of the American College of Cardiology.

[53]  G. Dobson,et al.  Intracellular, interstitial and plasma spaces in the rat myocardium in vivo. , 1997, Journal of molecular and cellular cardiology.

[54]  Robert M. Adamson,et al.  Right and Left Ventricular Function After Cardiac Transplantation: Changes During and After Rejection , 1991, Circulation.

[55]  J. Pickering,et al.  Fibrosis in the transplanted heart and its relation to donor ischemic time. Assessment with polarized light microscopy and digital image analysis. , 1990, Circulation.